ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto

Numero articolo: BIOV2696-25
Unità di misura: 25 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923724/image_1920?unique=67c7460

524,00 CHF 524.0 CHF 524,00 CHF

524,00 CHF

Not Available For Sale

    Questa combinazione non esiste.

    Tempo di consegna attuale su richiesta

    Produttore: BIOVISION
    Numero del produttore: 2696-25
    Temperatura di stoccaggio: Freezer (-20)

    ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto